HCG Oncology Network

CancerFax acts as your single coordinator across the entire HCG network. Because HCG operates 21 cancer hospitals across India, the first critical step is identifying which specific HCG centre is the right clinical and geographic fit for your case. You share your medical records — pathology, biopsy slides where re-review is requested, scans, prior treatment summaries and a current medication list — through our secure intake. Our clinical team reviews the case and identifies the HCG hospital that combines the right sub-specialty depth, the right advanced technology (CyberKnife or MR-LINAC for complex radiotherapy cases, da Vinci robotic surgery for selected indications, CAR T-cell therapy for eligible haematological cases, HIPEC for peritoneal cancers, paediatric BMT centres for childhood haematological malignancies) and reasonable proximity to your home or chosen international airport.

Once a clinical plan is confirmed, CancerFax prepares your full pre-travel pack: the chosen HCG centre's official cost estimate (shared with you without any CancerFax mark-up), Indian medical visa documentation, accommodation guidance in the relevant city, and a clear plan for the typical evaluation and treatment timeline. We remain your single point of contact through admission, treatment and follow-up. Where useful, we will openly compare HCG alongside alternative Indian pathways including Tata Memorial Hospital in Mumbai (India's national cancer flagship with subsidised public-sector pricing), AIIMS New Delhi, BLK-Max Delhi, MGM Cancer Institute Chennai and Apollo Cancer Centers, and international alternatives where these may be a better clinical fit. There is no fee to the patient for any of this coordination.

This is the most important practical question with HCG, and it depends on three factors: your cancer type and sub-specialty need; the specific advanced technology required (if any); and your travel logistics. For complex multi-modality cases — particularly those requiring CyberKnife S7 robotic radiosurgery, MR-LINAC (Elekta Unity), in-house Cyclotron-based theranostics, complex robotic surgery or paediatric BMT — the Bangalore K R Road flagship is typically the right destination. For Mumbai-based patients or international patients arriving via Mumbai BOM, the HCG ICS Khubchandani Cancer Centre in Colaba or HCG Cancer Hospital Borivali are both substantial centres with women's cancer care and international patient wings. For Ahmedabad/Gujarat patients, HCG Sola or HCG Aastha. For West India sarcoma or HIPEC cases, several HCG centres offer dedicated capability. For Karnataka tier-2 city patients, HCG Hubli (NMR), HCG Shimoga (Malnad) or HCG Kalaburagi/Gulbarga can deliver core cancer care closer to home for less complex cases. CancerFax assesses each case on these criteria and recommends the specific HCG centre that fits best.

Yes, HCG offers CAR T-cell therapy at selected centres, with the service listed formally on the HCG Oncology service line (CAR T Cell Therapy under hcgoncology.com/oncology-services/car-t-cell-therapy/). India's CAR T-cell therapy ecosystem is still relatively young compared with China, the United States and Western Europe — most Indian CAR T-cell therapy access is through clinical trials or via the indigenously developed NexCAR19 (the first India-approved CAR T-cell therapy for relapsed/refractory B-cell ALL and B-cell lymphoma). ⚠ VERIFY: specific CAR T-cell therapy products available at HCG, the specific HCG centres offering CAR T-cell therapy, the patient eligibility criteria and current waiting times before any clinical commitment. For patients seeking established high-volume CAR T-cell therapy options, CancerFax can openly compare HCG's emerging programme alongside the world's highest-volume CAR-T centres at Beijing GoBroad Boren Hospital (4,000+ CAR-T cases, 30 different CAR-T targets) and Lu Daopei Hospital in China, both with established CancerFax pathways. For HIPEC, robotic surgery, BMT, immunotherapy and targeted therapy, HCG's network offers genuinely established capability at multiple Indian centres.

Yes. HCG's clinical teams can review medical records and provide a specialist opinion remotely before a patient commits to travel. The process involves submitting your scans, pathology reports, prior treatment summaries and current medication list in English through the International Patient Services channel. CancerFax facilitates this submission and follows up with the chosen HCG clinical team on your behalf to obtain a written opinion or preliminary treatment recommendation. A remote opinion is particularly useful for HCG because it lets us identify the right HCG centre before you commit to international travel. CancerFax can also arrange parallel remote second opinions from Tata Memorial Hospital, AIIMS or international centres where this would be clinically useful, so the family can make a well-informed decision.

As a private Indian cancer hospital network, HCG offers cancer treatment at typical Indian private hospital pricing, which is materially lower than equivalent care in Singapore, the UK, the US or the Gulf — often by a factor of three to five for comparable surgical, radiation, medical and supportive care procedures. Within India, HCG's pricing is broadly comparable with other major private cancer networks (such as BLK-Max in Delhi or Apollo Cancer Centers across India) and is typically higher than public-sector cancer hospitals such as Tata Memorial Hospital in Mumbai (India's national cancer flagship, which combines world-class clinical capability with subsidised public-sector pricing for eligible Indian patients), AIIMS New Delhi or regional government cancer institutes. For Indian patients seeking subsidised national-level cancer care, CancerFax may openly discuss Tata Memorial as a complementary option. CancerFax shares HCG's official cost estimates with you at no extra charge and without any CancerFax mark-up. For Bangalore flagship pricing examples, room rates typically range from ₹4,000 to ₹18,000 per night depending on room category, and a chemotherapy cycle may cost between ₹20,000 and ₹1.5 lakh depending on the drugs used; these are illustrative figures only and the relevant HCG centre will provide a case-specific estimate.